113 related articles for article (PubMed ID: 8412484)
1. Plasma from patients with the pruritus of cholestasis induces opioid receptor-mediated scratching in monkeys.
Bergasa NV; Thomas DA; Vergalla J; Turner ML; Jones EA
Life Sci; 1993; 53(16):1253-7. PubMed ID: 8412484
[TBL] [Abstract][Full Text] [Related]
2. The medullary dorsal horn. A site of action of morphine in producing facial scratching in monkeys.
Thomas DA; Williams GM; Iwata K; Kenshalo DR; Dubner R
Anesthesiology; 1993 Sep; 79(3):548-54. PubMed ID: 8363081
[TBL] [Abstract][Full Text] [Related]
3. Multiple effects of morphine on facial scratching in monkeys.
Thomas DA; Williams GM; Iwata K; Kenshalo DR; Dubner R
Anesth Analg; 1993 Nov; 77(5):933-5. PubMed ID: 8214729
[TBL] [Abstract][Full Text] [Related]
4. Effects of central administration of opioids on facial scratching in monkeys.
Thomas DA; Williams GM; Iwata K; Kenshalo DR; Dubner R
Brain Res; 1992 Jul; 585(1-2):315-7. PubMed ID: 1511314
[TBL] [Abstract][Full Text] [Related]
5. Microinjection of morphine into the rat medullary dorsal horn produces a dose-dependent increase in facial scratching.
Thomas DA; Hammond DL
Brain Res; 1995 Oct; 695(2):267-70. PubMed ID: 8556343
[TBL] [Abstract][Full Text] [Related]
6. Noradrenergic and opioid systems interact to alter the detection of noxious thermal stimuli and facial scratching in monkeys.
Thomas DA; Anton F; Kenshalo DR; Williams GM; Dubner R
Pain; 1993 Oct; 55(1):63-70. PubMed ID: 7904058
[TBL] [Abstract][Full Text] [Related]
7. Nalfurafine, a kappa opioid receptor agonist, inhibits scratching behavior secondary to cholestasis induced by chronic ethynylestradiol injections in rats.
Inan S; Cowan A
Pharmacol Biochem Behav; 2006 Sep; 85(1):39-43. PubMed ID: 16919318
[TBL] [Abstract][Full Text] [Related]
8. The pruritus of cholestasis: From bile acids to opiate agonists: Relevant after all these years.
Bergasa NV
Med Hypotheses; 2018 Jan; 110():86-89. PubMed ID: 29317077
[TBL] [Abstract][Full Text] [Related]
9. Effects of naloxone infusions in patients with the pruritus of cholestasis. A double-blind, randomized, controlled trial.
Bergasa NV; Alling DW; Talbot TL; Swain MG; Yurdaydin C; Turner ML; Schmitt JM; Walker EC; Jones EA
Ann Intern Med; 1995 Aug; 123(3):161-7. PubMed ID: 7598296
[TBL] [Abstract][Full Text] [Related]
10. Evolving concepts of the pathogenesis and treatment of the pruritus of cholestasis.
Jones EA; Bergasa NV
Can J Gastroenterol; 2000 Jan; 14(1):33-40. PubMed ID: 10655025
[TBL] [Abstract][Full Text] [Related]
11. Opiate antagonist therapy for the pruritus of cholestasis: the avoidance of opioid withdrawal-like reactions.
Jones EA; Neuberger J; Bergasa NV
QJM; 2002 Aug; 95(8):547-52. PubMed ID: 12145394
[TBL] [Abstract][Full Text] [Related]
12. Endogenous opioid-mediated antinociception in cholestatic mice is peripherally, not centrally, mediated.
Nelson L; Vergnolle N; D'Mello C; Chapman K; Le T; Swain MG
J Hepatol; 2006 Jun; 44(6):1141-9. PubMed ID: 16466825
[TBL] [Abstract][Full Text] [Related]
13. Characterization of scratching behavior induced by intradermal administration of morphine and fentanyl in mice.
Yamamoto A; Kuyama S; Kamei C; Sugimoto Y
Eur J Pharmacol; 2010 Feb; 627(1-3):162-6. PubMed ID: 19900440
[TBL] [Abstract][Full Text] [Related]
14. Involvement of peripheral mu opioid receptors in scratching behavior in mice.
Yamamoto A; Sugimoto Y
Eur J Pharmacol; 2010 Dec; 649(1-3):336-41. PubMed ID: 20863827
[TBL] [Abstract][Full Text] [Related]
15. A controlled trial of naloxone infusions for the pruritus of chronic cholestasis.
Bergasa NV; Talbot TL; Alling DW; Schmitt JM; Walker EC; Baker BL; Korenman JC; Park Y; Hoofnagle JH; Jones EA
Gastroenterology; 1992 Feb; 102(2):544-9. PubMed ID: 1732125
[TBL] [Abstract][Full Text] [Related]
16. The pruritus of cholestasis: potential pathogenic and therapeutic implications of opioids.
Bergasa NV; Jones EA
Gastroenterology; 1995 May; 108(5):1582-8. PubMed ID: 7729651
[No Abstract] [Full Text] [Related]
17. The role of central mu opioid receptors in opioid-induced itch in primates.
Ko MC; Song MS; Edwards T; Lee H; Naughton NN
J Pharmacol Exp Ther; 2004 Jul; 310(1):169-76. PubMed ID: 15044556
[TBL] [Abstract][Full Text] [Related]
18. An experimental itch model in monkeys: characterization of intrathecal morphine-induced scratching and antinociception.
Ko MC; Naughton NN
Anesthesiology; 2000 Mar; 92(3):795-805. PubMed ID: 10719958
[TBL] [Abstract][Full Text] [Related]
19. Ondansetron and pruritus in chronic liver disease: a controlled study.
Jones EA; Molenaar HA; Oosting J
Hepatogastroenterology; 2007 Jun; 54(76):1196-9. PubMed ID: 17629069
[TBL] [Abstract][Full Text] [Related]
20. Spontaneous scratching behavior in MRL/lpr mice, a possible model for pruritus in autoimmune diseases, and antipruritic activity of a novel kappa-opioid receptor agonist nalfurafine hydrochloride.
Umeuchi H; Kawashima Y; Aoki CA; Kurokawa T; Nakao K; Itoh M; Kikuchi K; Kato T; Okano K; Gershwin ME; Miyakawa H
Eur J Pharmacol; 2005 Aug; 518(2-3):133-9. PubMed ID: 16055114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
